Hemolytic Disease of the Newborn
What is Hemolytic Disease of the Newborn?
Hemolytic disease of the newborn is a blood condition that happens when a mother and baby have incompatible blood types. When blood types do not match, the mother's immune system may create antibodies that attack the baby's red blood cells. This immune response can start during pregnancy or delivery when the baby's blood mixes with the mother's blood.
The most common cause involves Rh factor, a protein found on red blood cells. If a mother is Rh negative and her baby is Rh positive, her body may see the baby's cells as foreign. The mother's antibodies can cross the placenta and destroy the baby's red blood cells. This process is called hemolysis, which means the breaking down of red blood cells.
The condition can also happen with ABO blood type differences or other rare blood type incompatibilities. When too many red blood cells are destroyed, the baby may develop anemia, which means low hemoglobin levels. Severe cases can lead to jaundice, organ damage, or serious complications. Early detection through blood testing helps doctors monitor risk and provide treatment when needed.
Symptoms
- Yellowing of the skin and eyes, called jaundice
- Pale skin color due to anemia
- Rapid heart rate or fast breathing
- Swelling or fluid buildup in the body
- Enlarged liver or spleen
- Low muscle tone or weakness
- Poor feeding or difficulty eating
- Lethargy or decreased activity level
Many cases are detected before symptoms appear through routine prenatal screening. Mild cases may show only slight jaundice that resolves with treatment. Severe cases can cause serious symptoms that require immediate medical attention after birth.
Concerned about Hemolytic Disease of the Newborn? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
The main cause is blood type incompatibility between mother and baby. Rh incompatibility occurs when an Rh negative mother carries an Rh positive baby. ABO incompatibility happens when a mother with type O blood has a baby with type A or B blood. Other rare blood group differences can also trigger the condition. The mother's immune system creates antibodies against the baby's red blood cells during pregnancy or at delivery.
Risk factors include previous pregnancies with blood type differences, miscarriage, abortion, or blood transfusions that may have sensitized the mother's immune system. First pregnancies typically carry lower risk because the mother has not yet been exposed to incompatible blood. Each subsequent pregnancy with an incompatible baby increases antibody levels and risk. Events that cause maternal and fetal blood to mix, such as placental injury or certain prenatal procedures, also raise the risk of sensitization.
How it's diagnosed
Diagnosis begins with prenatal blood testing during pregnancy. An antibody screen detects whether the mother has developed antibodies against blood type factors. This screening is typically done early in pregnancy and again later for at-risk mothers. If antibodies are found, doctors monitor antibody levels throughout pregnancy to assess risk to the baby.
Hemoglobin testing helps identify anemia severity in affected babies. Doctors may also use ultrasound to check for signs of fetal anemia or fluid buildup. After birth, newborns at risk receive blood tests to measure hemoglobin levels, bilirubin levels, and blood type. Rite Aid offers antibody screening and hemoglobin testing through Quest Diagnostics locations nationwide. Early detection allows doctors to plan treatment and monitoring strategies to protect the baby's health.
Treatment options
- Rh immune globulin injections during pregnancy to prevent antibody formation in at-risk mothers
- Close monitoring of antibody levels and fetal health throughout pregnancy
- Phototherapy using special lights to break down excess bilirubin and treat jaundice
- Intravenous immunoglobulin therapy to reduce antibody effects
- Blood transfusions to replace destroyed red blood cells in severe cases
- Exchange transfusion to remove antibodies and replace the baby's blood in critical situations
- Early delivery if fetal health is declining
- Intrauterine blood transfusion for severely affected babies before birth
Concerned about Hemolytic Disease of the Newborn? Get tested at Rite Aid.
- Simple blood draw at your nearest lab
- Results in days, not weeks
- Share results with your doctor
Frequently asked questions
The condition is caused by blood type incompatibility between mother and baby. The mother's immune system creates antibodies that attack the baby's red blood cells. This happens most often with Rh factor differences or ABO blood type mismatches. The antibodies cross the placenta and destroy fetal red blood cells.
Doctors use an antibody screen blood test to check if the mother has developed antibodies against blood type factors. This screening happens early in pregnancy and may be repeated later for high-risk mothers. If antibodies are found, doctors monitor levels throughout pregnancy. Ultrasound may also detect signs of fetal anemia.
Yes, in many cases it can be prevented with Rh immune globulin injections. These shots are given to Rh negative mothers during pregnancy and after delivery. The medication prevents the mother's immune system from creating antibodies against Rh positive blood. Prevention is most effective when given before sensitization occurs.
Common signs include yellowing of the skin and eyes, pale skin, and swelling or fluid buildup. The baby may have an enlarged liver or spleen, feed poorly, or seem lethargic. Some babies show a rapid heart rate or breathing difficulties. Severe cases can cause serious complications that require immediate treatment.
Hemoglobin testing measures the amount of oxygen-carrying protein in red blood cells. Low hemoglobin levels indicate anemia from red blood cell destruction. Doctors use these results to assess severity and decide on treatment. Regular monitoring helps track whether the baby's condition is improving or worsening.
Yes, the condition often becomes more severe with each affected pregnancy. The mother's antibody levels typically increase after each exposure to incompatible blood. First pregnancies usually have lower risk because initial sensitization takes time. Later pregnancies may require closer monitoring and earlier intervention.
Treatment options include phototherapy to reduce jaundice, blood transfusions to replace destroyed cells, and immunoglobulin therapy. Severe cases may need exchange transfusion to remove antibodies and replace the baby's blood. Some babies require intrauterine transfusions before birth. Early delivery may be necessary if fetal health declines.
Yes, ABO incompatibility can cause hemolytic disease, though it is usually milder than Rh disease. This happens when a mother with type O blood has a baby with type A or B blood. The mother's naturally occurring antibodies can cross the placenta. Most cases are mild and respond well to phototherapy.
At-risk mothers typically have antibody screening early in pregnancy and again around 28 weeks. If antibodies are detected, testing frequency increases based on antibody levels and type. Some mothers need monthly or even weekly monitoring. Your doctor will create a testing schedule based on your individual risk factors.
Most babies treated promptly recover fully with no long-term effects. Severe untreated cases can cause brain damage from high bilirubin levels, a condition called kernicterus. Early detection and treatment greatly reduce the risk of complications. Regular follow-up care helps ensure healthy development after treatment.